This inventor holds 1 USPTO granted patent. Top assignee: Hucircadian Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Heon-Jeong Lee: Innovator in Mood Disorder Diagnosis
Introduction
Heon-Jeong Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of mental health through his innovative approaches to diagnosing mood disorders. His work focuses on utilizing circadian rhythms to provide objective assessments of mood-related conditions.
Latest Patents
Heon-Jeong Lee holds a patent for a method titled "Method for diagnosing mood disorder by using circadian rhythm." This patent outlines a diagnostic approach that allows for the clear and objective identification of mood disorders such as mania and depression. By analyzing the advance or delay of circadian rhythms, clinicians can quickly determine conditions like hypomania, mania, and mixed mania. This method not only aids in timely therapeutic interventions but also helps distinguish schizophrenia from severe depression or bipolar disorder. The ability to select appropriate therapeutic drugs is greatly enhanced through this innovative diagnostic method. Heon-Jeong Lee has 1 patent to his name.
Career Highlights
Heon-Jeong Lee is associated with Hucircadian Co., Ltd., where he continues to develop and refine his diagnostic methods. His work has garnered attention for its potential to revolutionize the way mood disorders are diagnosed and treated.
Collaborations
Heon-Jeong Lee collaborates with notable colleagues, including Chul-Hyun Cho and Joung-Ho Moon. Their combined expertise contributes to the advancement of research in the field of circadian rhythms and mental health.
Conclusion
Heon-Jeong Lee's innovative approach to diagnosing mood disorders through circadian rhythms represents a significant advancement in mental health diagnostics. His contributions have the potential to improve the lives of many individuals suffering from mood-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile